Medical News

RSS

Vitamin D deficiency predicts prostate biopsy outcomes

Men with vitamin D deficiency are more likely than men with normal levels to test positive for prostate cancer on biopsy, and to have aggressive disease, US researchers have found.

28 May 2014

Infant and adult weight interact to determine urinary incontinence risk

A woman’s weight at birth together with her weight in adulthood influence the risk of incident urinary incontinence, results of a nationwide twin study suggest.

28 May 2014

Physical therapy may not benefit hip osteoarthritis

Researchers have questioned the value of physical therapy for painful hip osteoarthritis in a study published in JAMA.

28 May 2014

Physical fitness should be considered in chronic neck pain management

Researchers recommend that clinicians consider whole body physical fitness, anxiety and depression when determining strategies for illness management in men and women with chronic neck pain.

28 May 2014

Contemporary dataset reveals burden of paediatric pneumococcal disease

Children with chronic or immunocompromising medical conditions continue to be at increased risk for developing pneumococcal disease in the current era of universal immunisation, US researchers report.

28 May 2014

JNC 8 blood pressure target for elderly queried

The systolic blood pressure of elderly people should be kept below 140 mmHg, say researchers who dispute the eighth Joint National Committee guidelines.

28 May 2014

Patrys reports positive results from PAT-SM6 clinical trial in patients with multiple myeloma

Patrys Limited, a clinical stage biotechnology company, is pleased to announce the clinical results from a patient treated with PAT-SM6 in combination with other marketed multiple myeloma drugs.

28 May 2014

BioTime receives ISO 13485:2003 certification for development of BioTime HyStem hydrogels

BioTime, Inc. today announced that it has received ISO 13485:2003 certification from BSI (British Standards Institution) for design, development, manufacture, and distribution of BioTime HyStem® hydrogels for cell delivery applications.

28 May 2014

Polyplus-transfection introduces FectoPRO transfection reagent

Polyplus-transfection SA, a privately-held company specializing in the development of innovative solutions for transfection, today announces the launch of FectoPRO, the latest optimised transfection reagent in their product portfolio. FectoPRO has been designed for high yields in medium and large-scale production of proteins and antibodies in mammalian cells.

28 May 2014

Superbugs decrease among patients after adding UVD to cleaning regimen

Healthcare-associated vancomycin-resistant enterococcus (VRE), methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile (CD), and other multidrug-resistant organisms (MDRO) were decreased among patients after adding ultraviolet environmental disinfection (UVD) to the cleaning regimen, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

28 May 2014

Transgenomic signs license with Dana-Farber to develop multiplexed ICE COLD-PCR technology

Transgenomic, Inc., a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has signed a license with the Dana-Farber Cancer Institute for worldwide rights to develop and commercialize multiplexed versions of its ICE COLD-PCRTM technology (MX ICE COLD-PCR).

28 May 2014

National Surgical Hospitals purchases interest in The Fairfield Surgery Center

National Surgical Hospitals, Inc., an owner, operator and developer of surgery centers and surgical hospitals in partnership with local physicians, today announced that it has purchased an interest in The Fairfield Surgery Center, LLC located in Fairfield, Connecticut.

28 May 2014

Princess Margaret signs MOU with Tata Memorial to pool cancer knowledge and expertise

Two world-renowned cancer centres today announced they will work together to further a shared vision of advancing innovation and delivery of best practices in all aspects of cancer care, research and education.

28 May 2014

Scientists collect new data on how "tumor suppressor" gene works

Scientists armed with a supercomputer and a vast trove of newly collected data on the body's most potent "tumor suppressor" gene have created the best map yet of how the gene works, an accomplishment that could lead to new techniques for fighting cancers, which are adept at disabling the gene in order to thrive.

28 May 2014

PCI | HealthDev adds Greg Pakes as Controller

PCI | HealthDev™ formerly Physicians' Capital Investments® (the Company), a leader in medical real estate development and medical investment solutions, is pleased to announce the addition of Greg Pakes as Controller.

28 May 2014

MRA announces acquisition of TrustHCS's cancer registry services division

Medical Record Associates, LLC, (MRA) announces the acquisition of TrustHCS's cancer registry services division. The acquisition of TrustHCS's cancer registry business compliments and expands MRA's existing cancer registry service offerings which assist healthcare customers in maintaining registry compliance, staffing registry programs and preparing for ACoS surveys.

28 May 2014

First Edition: May 28, 2014

Today's early morning highlights from the major news organizations, including reports about efforts to cut back spending on cancer care and the ouster of a key Army hospital administrator.

28 May 2014

CytRx announces Phase 2b clinical trial results of aldoxorubicin in subjects with metastatic STS

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas.

28 May 2014

Researchers recreate human lung in miniature with volume of half cubic centimeter

What medications can be used to treat lung cancer, and how effective are they? Until now, drug companies have had to rely on animal testing to find out. But in the future, a new 3D model lung is set to achieve more precise results and ultimately minimize - or even completely replace - animal testing. From June 23-26, researchers will be presenting their new model at the BIO International Convention in San Diego, California (Germany Pavilion, Booth 4513-03).

28 May 2014